AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TRISTEL PLC

Remuneration Information Jan 23, 2025

7990_dirs_2025-01-23_f5c93ccd-9690-4a0f-b35d-23370d2f4587.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 3495U

Tristel PLC

23 January 2025

Tristel plc

("Tristel" or the "Company")

Director Option Grant

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that on 22 January 2025 it granted a total of 127,468 new share options (the "Options") over ordinary shares of 1 pence each ("Ordinary Shares") under the new Long Term Incentive Plan ("LTIP") in the Company, to two directors as follows:

Director's name Position Number of Options granted Aggregate number of options post grant Current total beneficial holding of Ordinary Shares Current holding as a % of Issued share capital
Matt Sassone CEO 77,004 77,004 0 0
Liz Dixon CFO 50,464 50,464 1 50,000 0 .31

Terms of the new LTIP

The performance targets for the LTIP awards will be 50% based on earning per share (EPS) targets and 50% based on relative total shareholder return (TSR) versus the constituents of the AIM 100 as at the grant of the awards as follows:

50% of Initial awards 50% of Initial awards
EPS FY 26/27 % of EPS Part that Vests Relative TSR measured over 3 years from grant % of TSR Part that Vests
Less than 18p 0% Below median 0%
Between 18p and 25p Pro-rata 25% to 100% Between median and upper quartile Pro-rata 25% to 100%
25p or better 100% Upper quartile or above 100%

This announcement was deemed by the company to contain inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 as they form part of UK domestic law by virtue of the European Union (withdrawal) Act 2018. With the publication of this announcement, this information is now considered to be in the public domain.

For further information please contact:     

Tristel plc Via Walbrook PR
Matt Sassone, Chief Executive Officer www.investors.tristel.com
Liz Dixon, Chief Financial Officer
Walbrook PR Ltd Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391303
Cavendish Capital Markets Limited Tel: 020 7220 0500
Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance)
Sunila de Silva (ECM)

Louise Talbot (Sales)

About Tristel plc

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.

Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.

The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).

For more information about Tristel's product range please visit: https://tristel.com

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014 which forms part of UK Law by virtue of the European Union (Withdrawal) Act 2018.

1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Matthew Sassone
2. Reason for the Notification
a) Position/status CEO
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tristel plc
b) LEI 2138009DZ4LH9CZGF662
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of 1p each
Identification code GB00B07RVT99
b) Nature of the transaction Grant of options
c) Price(s) and volume(s) 1pence, 77,004 shares
d) Aggregated information:

· Aggregated volume

· Price
See above
e) Date of the transaction 22 January 2025
f) Place of the transaction Outside of a trading venue
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Elizabeth Dixon
2. Reason for the Notification
a) Position/status CFO
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tristel plc
b) LEI 2138009DZ4LH9CZGF662
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of 1p each
Identification code GB00B07RVT99
b) Nature of the transaction Grant of options
c) Price(s) and volume(s) 1 pence, 50,464 shares
d) Aggregated information:

· Aggregated volume

· Price
See above
e) Date of the transaction 22 January 2025
f) Place of the transaction Outside of a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPKBBKOBKDNDB

Talk to a Data Expert

Have a question? We'll get back to you promptly.